Cefixime & Linezolid Film-Coated Tablets (200 mg / 600 mg)

Healthy Inc is a specialized global supplier and exporter of advanced anti-infectives, critical care medicine, and targeted resistance-breaking therapeutics. We provide ultra-high-purity, kinetically balanced Cefixime & Linezolid Tablets, manufactured in WHO–GMP certified, dedicated high-containment antibiotic facilities. This “3rd-Gen Cephalosporin & Oxazolidinone FDC” is a premium-tier export to tertiary care hospitals, infectious disease clinics, and government health ministries, serving as the globally mandated intervention for skin and soft tissue infections (SSTI), complicated respiratory tract infections, and switch-therapy from IV Vancomycin or Ceftriaxone.

Product Overview

This formulation operates as a devastating, dual-front biochemical assault. It is designed to overcome the “Gram-Gap”—ensuring that while Cefixime eradicates resilient Gram-negative bacilli, Linezolid simultaneously destroys highly resistant Gram-positive “Superbugs” that are immune to standard penicillins.

• Mechanism 1 (The Cell Wall Executioner – Cefixime): Cefixime binds to Penicillin-Binding Proteins (PBPs), halting the transpeptidation step of bacterial cell wall synthesis. This causes the Gram-negative bacteria to physically rupture under osmotic pressure.

• Mechanism 2 (The Protein Synthesis Saboteur – Linezolid): Linezolid is a unique protein synthesis inhibitor. It binds to the 23S ribosomal RNA of the 50S subunit, preventing the formation of the functional 70S initiation complex. This stops the bacteria from manufacturing the proteins it needs to replicate.

• Mechanism 3 (The MRSA/VRE Solution): Linezolid provides the “heavy lifting” against Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococci (VRE), pathogens that typically require hospitalization for IV treatment.

Product Composition & Strength

We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive APIs.

Technical & Logistics Specifications

• HS Code: 3004.20.00 (Medicaments containing antibiotics)

• CAS Numbers: 79350-37-1 (Cefixime) / 165800-03-3 (Linezolid)

• Dosage Form: Film-Coated Tablet (Immediate Release)

• Packaging: Alu-Alu Blisters (MANDATORY). Linezolid is sensitive to light and moisture. Alu-Alu packaging ensures 24-month stability in Zone IVb tropical climates.

Manufacturing Authority & Compliance

• Dedicated Antibiotic Segregation: To eliminate cross-contamination risks, production occurs in Strictly Isolated Antibiotic Blocks with independent HVAC systems.

• Content Uniformity Mastery: Managing a 600mg dose of Linezolid alongside 200mg of Cefixime requires High-Shear Granulation. We guarantee 100% uniformity, ensuring the patient receives the exact clinical dose required to stop the “Superbug” in its tracks.

Dosage & Administration

• Standard Adult Dosing: 1 tablet taken twice daily (BID) for 10 to 14 days, strictly as per the specialist’s protocol.

• Administration: Can be taken with or without food. However, patients must avoid “Tyramine-rich” foods (aged cheese, red wine, soy sauce) as Linezolid acts as a mild, reversible MAO inhibitor.

Safety Warning: Strictly contraindicated in patients taking SSRIs or MAOIs (risk of fatal Serotonin Syndrome). Monitor CBC weekly for patients on prolonged therapy due to the risk of Myelosuppression (Thrombocytopenia). Avoid in patients with uncontrolled hypertension.

Global Export & Contract Manufacturing

Healthy Inc is a premier Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-end “Superbug” FDCs. Whether you are a Government Tender Supplier for critical care in Africa or a B2B Pharma Marketplace partner in the CIS, we ensure secure, WHO-GMP compliant delivery.